Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sinohealth Holdings Ltd. ( (HK:2361) ) has issued an update.
Sinohealth Technology Holdings Limited has scheduled a board meeting for 27 March 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider the publication of these results and discuss whether to recommend a final dividend, a decision that could affect shareholder returns and signal management’s confidence in the group’s financial performance.
The announcement, signed by chairman Wu Yushu on 13 March 2026, confirms the current composition of the board, which includes two executive directors, one non-executive director and three independent non-executive directors. This forthcoming meeting marks a key event in Sinohealth’s financial calendar and will provide investors and other stakeholders with an updated view of the company’s operational and financial health for 2025.
More about Sinohealth Holdings Ltd.
Sinohealth Technology Holdings Limited, formerly known as Sinohealth Holdings Limited, is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 2361. The company operates through a board comprising executive, non-executive and independent non-executive directors, reflecting a standard corporate governance structure for a Hong Kong-listed issuer.
Average Trading Volume: 15,321
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.12B
See more data about 2361 stock on TipRanks’ Stock Analysis page.